Zentalis Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.22

-0.78 (-15.60%)

As of Aug 9, 10:41 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 63%

Hold 6 38%

Sell 0 0%

Price Target

Analyst Price Target +541.9% upside

Low Target $17.95

Average Target $27.09

High Target $27.14

Current Price $4.22

Current
$4.22

Target
$27.09

$17.95 $27.09 avg $27.14

Scenario Analysis

Bear Case

$17.95

325.4%

Low target

Base Case

$27.09

+541.9%

Avg target

Bull Case

$27.14

+543.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$6.95

-39.3% from high

52-Week Low

$1.21

+248.2% from low

Target vs 52W High

$27.09

+289.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%